Ticker
VYNECompany Name
VYNE THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Earnings Yield | Market Capitalization | Net Income Common Stock |
---|---|---|---|
6/30/2025 | -432.35% | $ 8.92M | $ -38.55M |
3/31/2025 | -194.77% | $ 21.66M | $ -42.2M |
12/31/2024 | -112.4% | $ 35.44M | $ -39.83M |
9/30/2024 | -73.05% | $ 46.54M | $ -34M |
6/30/2024 | -111.41% | $ 25.52M | $ -28.43M |
3/31/2024 | -75.53% | $ 38.5M | $ -29.08M |
12/31/2023 | -90.9% | $ 31.3M | $ -28.45M |
9/30/2023 | -66.31% | $ 48.57M | $ -32.21M |
6/30/2023 | -177.98% | $ 19.71M | $ -35.08M |
3/31/2023 | -167.89% | $ 19.95M | $ -33.5M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
Net Inc. Cmn. / Market Cap
(=) Earnings Yield
Earnings Yield for VYNE THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -253.88M ] / Market Cap [ $ 297.15M ]
(=) Earnings Yield [ -85.44% ]
Minimum
Jun 30, 2025
Maximum
Sep 30, 2023
Average
Median
filtered constituents | 3.42K |
---|---|
min | -31.68% |
max | 32.87% |
average | 0.34% |
median | 2.78% |
std | 9.81% |